China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Value of combined GPⅠa/CYP2C19 polymorphisms for AIS short‑term prognosis and recurrence'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131744
Registration Time: 2026/09/06
Type: Observational study
Primary Sponsor: Ningbo Medical Centre Lihuili Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=304625
Published by HT Digital Content Services with permission from Health Daily Digest....